Simpson Jennifer K. 4
4 · Panbela Therapeutics, Inc. · Filed Feb 1, 2023
Insider Transaction Report
Form 4
Simpson Jennifer K.
DirectorPresident and CEO
Transactions
- Purchase
Warrants (right to buy)
2023-01-30+8,888→ 8,888 totalExercise: $2.75From: 2023-01-30Exp: 2028-01-30→ Common Stock (8,888 underlying) - Purchase
Common Stock
2023-01-30+4,444→ 7,868 total
Footnotes (2)
- [F1]Reported securities purchased as one share of common stock and one warrant to purchase two shares of common stock for a combined price of $2.25 per share and warrant.
- [F2]On or after March 1, 2023, holder may elect an "alternative cashless exercise" pursuant to which they would receive an aggregate number of shares of common stock equal to 75% of the aggregate number of shares that would be issuable upon a cash exercise.